CureledgerCureledger
ReferencesBlog
Join

Blog

The case for patient-controlled rare disease data across science, policy, and the lived experience.

Featured

Patient Experience

What we still have to do

The structural friction of rare disease daily life.

Read →

This week

Data Sovereignty

Unpaid data farmers

The data work we have been doing for free, finally compensated.

Read →
Vision

The flywheel

Cohort proof licensed. Contribution measured. Deposit lands.

Read →
Science & Data

Cohort proofs

Privacy from cryptography. Validation without exposure.

Read →

Search articles

Browse by tag

Clear ×
Patient ExperienceData SovereigntyVisionScience & DataRegulatoryUltra-rareAccelerating innovationEhlers-DanlosNewborn screeningCompanyHistory
Read all6 of 116 · Tag: Data Sovereignty
↓
  1. Jul 13, 2026Unpaid data farmersData Sovereignty
  2. Jun 22, 2026What a trust is, and why this oneData Sovereignty
  3. Jun 8, 2026Cureledger is your ledgerData Sovereignty
  4. May 25, 2026Preventing AI medicine's biggest trap for rare diseaseData Sovereignty
  5. Apr 22, 2026You Are Not a SubjectData Sovereignty
  6. Apr 22, 2026We Are Not 23andMeData Sovereignty
About·For investors·Privacy··

© 2026 Cureledger Inc. · Raleigh, NC USA